Jubilant Pharma has launched Jubilant Radiopharma, a new company that will bring its Jubilant DraxImage Radiopharmacies and Jubilant DraxImage radiopharmaceutical development businesses together under the umbrella of a single radiopharmaceutical brand.
Jubilant noted that it has also recently upgraded its lyophilized and radioactive production lines, and has signed on secondary suppliers of active pharmaceutical ingredient and radiochemical products. In addition, the company said it has upgraded and expanded its radiopharmacy network and has plans to further expand its radiopharmacy footprint in the U.S.
Jubilant Radiopharma also reiterated its strategy of investing in early- and late-stage research and development of radiopharmaceuticals.
